Aditxt, Inc. financial data

Symbol
ADTX on Nasdaq
Industry
Pharmaceutical Preparations
Location
737 N. Fifth Street, Suite 200, Richmond, VA
State of incorporation
DE
Fiscal year end
December 31
Former names
ADiTx Therapeutics, Inc. (to 7/6/2021), Aditx Therapeutics, Inc. (to 7/6/2021)
Latest financial report
10-K - Q4 2024 - Mar 31, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 8.4 % -69.3%
Quick Ratio 1.5 %
Debt-to-equity 412 % -44.5%
Return On Equity -788 % +51.7%
Return On Assets -136 % +29.4%
Operating Margin -20.8K % -415%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 1.16M shares -30.4%
Common Stock, Shares, Outstanding 130K shares
Entity Public Float 2.73M USD -9.16%
Common Stock, Value, Issued 130 USD +1082%
Weighted Average Number of Shares Outstanding, Basic 13.2K shares +990%
Weighted Average Number of Shares Outstanding, Diluted 13.2K shares +990%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 134K USD -79.2%
Cost of Revenue 627K USD -17.1%
Research and Development Expense 10.9M USD +53.9%
Selling and Marketing Expense 198K USD -26.5%
General and Administrative Expense 16.3M USD -12.5%
Operating Income (Loss) -27.9M USD -6.91%
Nonoperating Income (Expense) -7.16M USD -13.1%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -35M USD -8.12%
Net Income (Loss) Attributable to Parent -40.4M USD -23.4%
Earnings Per Share, Basic -3.06K USD/shares
Earnings Per Share, Diluted -3.06K USD/shares

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 833K USD +758%
Accounts Receivable, after Allowance for Credit Loss, Current 43.4K USD -89.4%
Inventory, Net 11.2K USD -98.5%
Assets, Current 2M USD -71.1%
Property, Plant and Equipment, Net 1.55M USD -18.5%
Operating Lease, Right-of-Use Asset 1.23M USD -44.3%
Intangible Assets, Net (Excluding Goodwill) 6.11K USD -35.3%
Assets 32.1M USD -27.9%
Accounts Payable, Current 10.2M USD +35.5%
Accrued Liabilities, Current 1.89M USD +387%
Liabilities, Current 23.4M USD -9.59%
Operating Lease, Liability, Noncurrent 436K USD -58.1%
Liabilities 23.9M USD -16.4%
Retained Earnings (Accumulated Deficit) -168M USD -31.6%
Stockholders' Equity Attributable to Parent 497K USD -96.9%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest -86.6K USD -101%
Liabilities and Equity 32.1M USD -27.9%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -5.96M USD -50.8%
Net Cash Provided by (Used in) Financing Activities 5.95M USD +299%
Net Cash Provided by (Used in) Investing Activities -5.05K USD +98.6%
Common Stock, Shares Authorized 1B shares +900%
Common Stock, Shares, Issued 130K shares
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -2.47M USD +57.2%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 833K USD +758%
Interest Paid, Excluding Capitalized Interest, Operating Activities 623K USD +222%
Deferred Tax Assets, Valuation Allowance 34.6M USD +30.8%
Deferred Tax Assets, Gross 35M USD +29.3%
Operating Lease, Liability 1.12M USD -45.2%
Depreciation 614K USD +41.1%
Payments to Acquire Property, Plant, and Equipment 5.05K USD
Lessee, Operating Lease, Liability, to be Paid 1.13M USD
Property, Plant and Equipment, Gross 3.39M USD +7.66%
Operating Lease, Liability, Current 683K USD -31.7%
Lessee, Operating Lease, Liability, to be Paid, Year Two 424K USD -40.3%
Lessee, Operating Lease, Liability, to be Paid, Year One 711K USD -29.3%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 14.8K USD -84.9%
Lessee, Operating Lease, Liability, to be Paid, Year Three 424K USD -40.3%
Deferred Tax Assets, Operating Loss Carryforwards 24.7M USD +33.2%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 3M shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 424K USD
Additional Paid in Capital 169M USD +17.2%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 3.33K USD -96.9%
Deferred Tax Assets, Net of Valuation Allowance 630K USD -29.8%
Operating Leases, Future Minimum Payments Due 1.42M USD
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%